Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course Of Bleomycin And Etoposide Plus Cisplatin Chemotherapy

�UroToday.com - In the June 20, 2008 issue of the Journal of Clinical Oncology, Dr. Peter Albers and colleagues presented the results of a large randomised German trial in work force with stage I nonseminomatous germ cellular telephone tumors (NSGCT). The treatment options for these patients included active surveillance, retroperitoneal lymphadenectomy (RPLND), or one course of BEP chemotherapy. The hypothesis of the study was that